94 related articles for article (PubMed ID: 9745188)
1. Effect of interferon therapy on heart rate and sympathetic nervous system.
Yamamoto T; Tsuchihashi T; Hayashi J; Kashiwagi S
Fukuoka Igaku Zasshi; 1998 Jul; 89(7):207-15. PubMed ID: 9745188
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA.
Shiratori Y; Yokosuka O; Nakata R; Ihori M; Hirota K; Katamoto T; Unuma T; Okano K; Ikeda Y; Hirano M; Kawase T; Takano S; Matsumoto K; Ohashi Y; Omata M
Hepatology; 1999 May; 29(5):1573-80. PubMed ID: 10216145
[TBL] [Abstract][Full Text] [Related]
3. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
[TBL] [Abstract][Full Text] [Related]
4. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
[TBL] [Abstract][Full Text] [Related]
5. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.
Toccaceli F; Rosati S; Scuderi M; Iacomi F; Picconi R; Laghi V
Hepatogastroenterology; 1998; 45(23):1748-52. PubMed ID: 9840140
[TBL] [Abstract][Full Text] [Related]
7. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
[TBL] [Abstract][Full Text] [Related]
8. The experience of interferon-based treatments for hepatitis C infection.
Hopwood M; Treloar C
Qual Health Res; 2005 May; 15(5):635-46. PubMed ID: 15802540
[TBL] [Abstract][Full Text] [Related]
9. [The neuropsychiatric side effects of the interferon therapy in patients with chronic hepatitis B and C].
Lapiński TW; Prokopowicz D
Pol Merkur Lekarski; 1999 Jul; 7(37):8-11. PubMed ID: 10522402
[TBL] [Abstract][Full Text] [Related]
10. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.
Kumar KS; Russo MW; Borczuk AC; Brown M; Esposito SP; Lobritto SJ; Jacobson IM; Brown RS
Am J Gastroenterol; 2002 Sep; 97(9):2432-40. PubMed ID: 12358269
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group.
Reddy KR; Hoofnagle JH; Tong MJ; Lee WM; Pockros P; Heathcote EJ; Albert D; Joh T
Hepatology; 1999 Sep; 30(3):787-93. PubMed ID: 10462387
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.
Hauser P; Khosla J; Aurora H; Laurin J; Kling MA; Hill J; Gulati M; Thornton AJ; Schultz RL; Valentine AD; Meyers CA; Howell CD
Mol Psychiatry; 2002; 7(9):942-7. PubMed ID: 12399946
[TBL] [Abstract][Full Text] [Related]
13. Twice-a-day versus once-a-day interferon-beta therapy in chronic hepatitis C.
Kaito M; Yasui-Kawamura N; Iwasa M; Kobayashi Y; Nakagawa N; Fujita N; Ikoma J; Gabazza EC; Watanabe S; Adachi Y
Hepatogastroenterology; 2003; 50(51):775-8. PubMed ID: 12828083
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of acute hepatitis C].
García Compeán D
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S61-6. PubMed ID: 12712857
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
16. IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C.
Sharvadze L; Gochitashvili N; Tophuria A; Bolokadze N; Tsertsvadze T
Georgian Med News; 2007 Jun; (147):52-5. PubMed ID: 17660602
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.
Bonny C; Fontaine H; Poynard T; Hézode C; Larrey D; Marcellin P; Bourlière M; Bronowicki JP; Merle P; Zarski JP; Sapey T; Guillemard C; Ughetto S; Henquell C; Nicolas C; Roche C; Randl K; Bommelaer G; Abergel A
Aliment Pharmacol Ther; 2006 Aug; 24(4):593-600. PubMed ID: 16907892
[TBL] [Abstract][Full Text] [Related]
18. Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C.
Naeem M; Bacon BR; Mistry B; Britton RS; Di Bisceglie AM
Am J Gastroenterol; 2001 Aug; 96(8):2468-72. PubMed ID: 11513192
[TBL] [Abstract][Full Text] [Related]
19. Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or death.
Costiniuk CT; Camacho F; Cooper CL
Clin Infect Dis; 2008 Jul; 47(2):198-202. PubMed ID: 18532889
[TBL] [Abstract][Full Text] [Related]
20. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
